Curated News
By: NewsRamp Editorial Staff
October 08, 2026
SS Innovations Builds Telerobotic Surgery Position as Remote Procedures Gain Ground
TLDR
- SS Innovations SSi Mantra base grew 45 percent to 244 systems, positioning SSII ahead in telerobotic surgery expansion.
- SSi Mantra enables telesurgery by testing distance limits while maintaining responsiveness, with 195 remote procedures and 14,503 cumulative cases.
- Telerobotic surgery with SSi Mantra brings specialized cardiac care to 12 countries, improving access for patients in underserved regions.
- SS Innovations SSi Mantra has enabled 195 telesurgeries, including long-distance cardiac operations, while pursuing FDA and CE clearance.
Impact - Why it Matters
Telerobotic surgery has the potential to reshape global healthcare by extending the reach of specialized surgeons to remote and underserved regions. SS Innovations’ progress—195 telesurgeries and a 45% increase in installed systems—demonstrates that remote procedures are becoming clinically viable. If the company secures FDA clearance and CE marking, it could accelerate adoption in the U.S. and Europe, intensifying competition in the surgical robotics market and offering patients broader access to advanced care. This matters because it signals a shift toward a future where geography no longer limits access to expert surgical intervention.
Summary
Telerobotic surgery is moving from isolated demonstrations toward broader clinical and regulatory development, and SS Innovations International (NASDAQ: SSII) is positioning itself at the center of that shift. A recent MedTech Dive report, “Telerobotic surgery is advancing around the world. Will the US embrace it?,” examined the technology’s global progress and the regulatory and infrastructure questions surrounding remote surgery. The article highlighted SS Innovations alongside larger medical-device companies and emerging robotics developers, underscoring the company’s growing relevance in the surgical robotics market.
SS Innovations founder and CEO Dr. Sudhir Srivastava, a cardiac surgeon, told MedTech Dive that robotic surgery is inherently a form of teleoperation and that the central technical question is how much distance can be introduced without compromising responsiveness. The company’s SSi Mantra system has accumulated 195 robotic telesurgeries as of Sept. 28, 2026, including cardiac procedures and long-distance operations. Its installed base reached 244 SSi Mantra systems as of that date, up 45% from the end of 2025, while cumulative procedures climbed to 14,503. The system has expanded into 12 countries, with recent cardiac-surgery programs launched in Colombia and Sri Lanka and a new program established at HCG Hospital in Ahmedabad. SS Innovations is currently pursuing U.S. FDA clearance and European Union CE marking as it seeks to expand into additional international markets. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII, and the full article can be read via the Read More link.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, SS Innovations Builds Telerobotic Surgery Position as Remote Procedures Gain Ground
